IL-10 induction properties of the TLR-9 agonist cobitolimod - a candidate for treatment of active ulcerative colitis in late stage of clinical development

Admyre C, Zargari A, Atreya R, Knittel T (2017)

Publication Type: Conference contribution

Publication year: 2017

Journal

Journal of Crohns & Colitis Elsevier

Book Volume: 11

Pages Range: S117-S117

Authors with CRIS profile

Raja Atreya Professur für Translationale Immunforschung bei chronisch entzündlichen Darmerkrankungen (Heisenberg-Professur)

Involved external institutions

InDex Pharmaceuticals SE Sweden (SE)

How to cite

APA:

Admyre, C., Zargari, A., Atreya, R., & Knittel, T. (2017). IL-10 induction properties of the TLR-9 agonist cobitolimod - a candidate for treatment of active ulcerative colitis in late stage of clinical development. (pp. S117-S117).

MLA:

Admyre, C., et al. "IL-10 induction properties of the TLR-9 agonist cobitolimod - a candidate for treatment of active ulcerative colitis in late stage of clinical development." 2017. S117-S117.

BibTeX: Download